Skip to main content
×
×
Home

The effect of timing of oseltamivir chemoprophylaxis in controlling influenza A H3N2 outbreaks in long-term care facilities in Manitoba, Canada, 2014-2015: a retrospective cohort study

  • Davinder Singh (a1), Depeng Jiang (a1), Paul Van Caeseele (a2) and Carla Loeppky (a1)
Abstract
Objective

This study examined the effect of the timing of administration of oseltamivir chemoprophylaxis for the control of influenza A H3N2 outbreaks among residents in long-term care facilities (LTCFs) in Manitoba, Canada, during the 2014–2015 influenza season.

Methods

A retrospective cohort study was conducted of all LTCF influenza A H3N2 outbreaks (n=94) using a hierarchical logistic regression analysis. The main independent variable was how many days passed between the start of the outbreak and commencement of oseltamivir chemoprophylaxis. The dependent variable was whether each person in the institution developed influenza-like illness (yes or no).

Results

Delay of oseltamivir chemoprophylaxis was associated with increased odds of infection in both univariate (t=5·41; df=51; P<·0001) and multivariable analyses (t=6·04; df=49; P<·0001) with an adjusted odds ratio of 1.3 (95% confidence interval [CI], 1·2–1·5) per day for influenza A H3N2.

Conclusions

The sooner chemoprophylaxis is initiated, the lower the odds of secondary infection with influenza in LTCFs during outbreaks caused by influenza A H3N2 in Manitoba. For every day that passed from the start of the outbreak to the initiation of oseltamivir, the odds of a resident at risk of infection in the facility developing symptomatic infection increased by 33%.

Copyright
Corresponding author
Author for correspondence: Dr Davinder Singh, Department of Community Health Sciences, University of Manitoba, S111-750 Bannatyne Avenue, Winnipeg, MB, Canada, R3E 0W3. E-mail: umsing67@myumanitoba.ca
Footnotes
Hide All

PREVIOUS PRESENTATION: A preliminary study was published in 2016 in the Canadian Journal of Infection Control. The current study is significantly larger with a more in-depth analysis

Cite this article: Singh D, et al. (2018). The effect of timing of oseltamivir chemoprophylaxis in controlling influenza A H3N2 outbreaks in long-term care facilities in manitoba, canada, 2014-2015: a retrospective cohort study. Infection Control & Hospital Epidemiology 2018, 1–6. doi:10.1017/ice.2018.115

Footnotes
References
Hide All
1. National Advisory Committee on Immunization. Statement on Seasonal Influenza Vaccine for 2015–2016. Government of Canada website. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/statement-on-seasonal-influenza-vaccine-2015-2016.html. Published 2015. Accessed May 1, 2018.
2. Jefferson, T, Di Pietrantonj, C, Al-Ansary, LA, Ferroni, E, Thorning, S, Thomas, RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010;17:CD004876.
3. Last, JM. A Dictionary of Epidemiology. 2nd ed. Toronto, ON: Oxford University Press; 1988.
4. Canadian Institute for Health Information. Health Care in Canada, 2011: A Focus on Seniors and Aging. Ottawa, ON: CIHI; 2011.
5. Booy, R, Lindley, RI, Dwyer, DE, et al. Treating and preventing influenza in aged care facilities: a cluster randomised controlled trial. PloS One 2012;7:e46509.
6. Bowles, SK, Lee, W, Simor, AE, et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999–2000. J Am Geriatr Soc 2002;50:608616.
7. Gorisek Miksic, N, Ursic, T, Simonovic, Z, et al. Oseltamivir prophylaxis in controlling influenza outbreak in nursing homes: a comparison between three different approaches. Infection 2015;43:7381.
8. Peters, PH Jr., Gravenstein, S, Norwood, P, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001;49:10251031.
9. Communicable disease management protocol: seasonal influenza. Manitoba Public Health Branch website. http://www.gov.mb.ca/health/publichealth/cdc/protocol/influenza1.pdf. Published August 2016. Accessed May 1, 2018.
10. Harper, SA, Bradley, JS, Englund, JA, et al. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:10031032.
11. Hayden, FG, Belshe, R, Villanueva, C, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004;189:440449.
12. van der Sande, MA, Meijer, A, Sen-Kerpiclik, F, et al. Effectiveness of post-exposition prophylaxis with oseltamivir in nursing homes: a randomised controlled trial over four seasons. Emerg Themes Epidemiol 2014;11:13.
13. Manitoba Health, Seniors and Active Living. Influenza surveillance weekly report: week 22. Government of Canada website. https://www.gov.mb.ca/health/publichealth/surveillance/influenza/docs/150606.pdf Published June 6, 2015. Accessed May 1, 2018.
14. Estevez, E. (Manitoba Health, Seniors and Active Living, Winnipeg, MB). Conversation with: Davinder Singh (University of Manitoba, Winnipeg, MB). Aug 17, 2016.
15. Monto, AS, Rotthoff, J, Teich, E, et al. Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis 2004;39:459464.
16. van der Sande, MA, Ruijs, WL, Meijer, A, Cools, HJ, van der Plas, SM. Use of oseltamivir in Dutch nursing homes during the 2004–2005 influenza season. Vaccine 2006;24:66646669.
17. Welliver, R, Monto, AS, Carewicz, O, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001;285:748754.
18. Millership, S, Cummins, A. Oseltamivir in influenza outbreaks in care homes: challenges and benefits of use in the real world. J Hosp Infect 2015;90:299303.
19. Ye, M, Jacobs, A, Khan, MN, et al. Evaluation of the use of oseltamivir prophylaxis in the control of influenza outbreaks in long-term care facilities in Alberta, Canada: a retrospective provincial database analysis. BMJ Open 2016;6:e011686.
20. Canadian Institute for Health Information. Health Workforce Database, 2015: Methodology Guide. Ottawa, ON: CIHI; 2016.
21. Gregg, M. Field Epidemiology. 3rd ed. Toronto, ON: Oxford University Press; 2008.
22. Singh, D, Robinson, K, Hilderman, T. The effect of timing of oseltamivir chemoprophylaxis in controlling influenza A H3N2 outbreaks in long term care facilities in Eastern Manitoba, Canada, 2014–2015: a retrospective cohort study. Can J Infect Control 2016;31:221224.
23. Gilca, R, Skowronski, DM, Douville-Fradet, M, et al. Mid-season estimates of influenza vaccine effectiveness against influenza A(H3N2) hospitalization in the elderly in Quebec, Canada, January 2015. PloS One 2015;10:e0132195.
24. Smith, PW, Bennett, G, Bradley, S, et al. SHEA/APIC Guideline: infection prevention and control in the long-term care facility. Am J Infect Control 2008;36:504535.
25. The Regional Office for Europe of the World Health Organization. Prevention and Control of Outbreaks of Seasonal Influenza in Long-Term Care Facilities: A Review of the Evidence and Best-Practice Guidelines. Copenhagen, Denmark: World Health Organization; 2017.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 5
Total number of PDF views: 35 *
Loading metrics...

Abstract views

Total abstract views: 277 *
Loading metrics...

* Views captured on Cambridge Core between 12th June 2018 - 25th June 2018. This data will be updated every 24 hours.